基于CRISPR/Cas12a的传感用于HCC诊断的新方法 - 一个审查 (2020-2025)
Cunhong Cen1, Xiyu Liu1, Wei He1
1State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning 530021, China.
Journal of pharmaceutical and biomedical analysis
|April 10, 2025
概括
克里斯普尔/Cas12a生物传感器为早期肝细胞癌 (HCC) 检测提供了一种敏感和特定的方法. 本综述详细介绍了它们的原理,应用和未来的临床潜力,并解决了传统方法的局限性.
科学领域:
- 生物技术是生物技术.
- 分子诊断学 分子诊断
- 在瘤学瘤学.
背景情况:
- 肝细胞癌 (HCC) 的早期诊断对于患者的生存和治疗疗效至关重要.
- 对于HCC生物标志物的传统检测方法往往缺乏足够的灵敏度和特异性.
- 基于CRISPR/Cas12a的生物感知是一种有前途的替代方案,因为它具有很高的灵敏度和易于使用.
研究的目的:
- 审查基于CRISPR/Cas12a的生物传感器用于HCC检测的研究进展.
- 介绍这些生物传感器的原理 (光,电化学,色度) 和应用.
- 为了比较分析不同CRISPR/Cas12a生物传感器类型的性能 (灵敏度,特异性,速度).
主要方法:
- 审查关于CRISPR/Cas12a生物传感器的现有文献.
- 检测原理的分析,包括光,电化学和色度测试.
- 对传感器性能指标的比较评估.
主要成果:
- 克里斯普尔/Cas12a生物传感器在克服传统HCC检测方法的局限性方面具有显著的潜力.
- 各种CRISPR/Cas12a生物传感器平台在灵敏度,特异性和检测速度方面具有明显的优势.
- 详细介绍了这些先进生物传感器的实际应用和性能特征.
结论:
- 克里斯普尔/Cas12a技术对敏感和特定的HCC早期检测具有重大前景.
- 这些生物传感器的进一步开发和临床转化可以显著改善患者的治疗结果.
- 未来的研究应该专注于优化传感器设计和验证临床环境中的性能.
相关概念视频
CRISPR and crRNAs
16.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.3K
CRISPR
48.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.6K
Homologous Recombination
49.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
49.9K


